1.Utility of Optical Coherence Tomography to Assess a Hazy Intracoronary Image after Percutaneous Coronary Intervention.
Sebastian CARRIZO ; Pablo SALINAS ; Santiago JIMENEZ-VALERO ; Raul MORENO
Korean Circulation Journal 2013;43(1):44-47
Although its use in daily practice is not common, optical coherence tomography (OCT) is a powerful research tool in invasive cardiology. This report describes a hazy angiography image after percutaneous coronary intervention that has been assessed using OCT. Based on the results of the OCT, the patient underwent an elective coronary angioplasty with standard anticoagulation. After implantation of the stent, an intracoronary hazy image was seen on angiography. The use of OCT permitted a correct diagnosis and a successful treatment. This paper provides a discussion of the advantages and disadvantages of OCT, and a comparison with intravascular ultrasound.
Angiography
;
Angioplasty
;
Cardiac Catheterization
;
Cardiology
;
Humans
;
Percutaneous Coronary Intervention
;
Stents
;
Thrombosis
;
Tomography, Optical Coherence
;
Ultrasonography, Interventional
2.Comparative Safety of Long-Acting Injectable Antipsychotics: A Systematic Review and Network Meta-Analysis
Erasmo Saucedo URIBE ; Samuel Enrique Olivares MUNDO ; Raul Ricardo Medrano GARZA ; Fernando Diaz GONZALEZ-COLMENERO ; Lorena Martinez SANCHEZ ; Cesar Bigran Espinosa CANTU ; Martin Moreno ARELLANO ; Yessica Yaneth Herrera MONTEMAYOR ; Patricia Lizeth Castillo MORALES ; Samantha Berenice Medrano JUAREZ ; Sandra Sabrina ROJO-GARZA
Psychiatry Investigation 2023;20(12):1112-1125
Objective:
To find the safety of long-acting injectable antipsychotics (LAIs) compared to each other, and/or placebo in the treatment of schizophrenia (SCZ) and/or schizoaffective disorder (SZA).
Methods:
We performed a systematic review and a network meta-analysis of randomized controlled trials (RCTs) comparing the safety of LAIs versus other LAIs or placebo in adults diagnosed with SCZ or SZA. The primary outcomes were treatment emergent adverse events (TEAEs), serious treatment emergent adverse events (STEAEs), and deaths. The secondary outcomes included treatment discontinuations due to adverse events and all-cause discontinuations.
Results:
Seventeen RCTs were included (n=7,908). There were no significant differences between LAIs and placebo in the risk of presenting TEAEs. LAIs had a significant lower risk of presenting STEAEs except for aripiprazole. No significant differences in deaths were found. LAIs showed a significant protective effect against all-cause discontinuation, except for haloperidol. Only aripiprazole had a significantly lower risk of treatment discontinuation due to adverse events.
Conclusion
We found no significant differences in the risk of presenting TEAEs between LAIs and placebo. The majority of LAIs had a significantly lower risk of presenting STEAEs than placebo. Development of international guidelines for the report of safety outcomes related to antipsychotics especially for LAIs in clinical trials could minimize report and interpretation biases and improve the accuracy of posterior meta-analysis.
3.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO
The World Journal of Men's Health 2025;43(1):249-258
Purpose:
Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population.
Materials and Methods:
This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:
We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions
Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population.
4.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO
The World Journal of Men's Health 2025;43(1):249-258
Purpose:
Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population.
Materials and Methods:
This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:
We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions
Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population.
5.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO
The World Journal of Men's Health 2025;43(1):249-258
Purpose:
Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population.
Materials and Methods:
This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:
We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions
Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population.
6.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO
The World Journal of Men's Health 2025;43(1):249-258
Purpose:
Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population.
Materials and Methods:
This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:
We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions
Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population.
7.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO
The World Journal of Men's Health 2025;43(1):249-258
Purpose:
Cardiovascular disease (CVD) is more prevalent in men than women, but the mechanisms responsible for this are not fully understood. We aimed to evaluate differences in trimethylamine (TMA), a microbial metabolite and its oxidized form, trimethylamine N-oxide (TMAO), which is thought to promote atherosclerosis, between men and women with coronary heart disease (CHD), using as a reference a non-CVD population.
Materials and Methods:
This study was carried out within the framework of the CORDIOPREV study (NCT00924937; June 19, 2009), a clinical trial which included 827 men and 175 women with CHD, with a non-CVD population of 375 individuals (270 men and 105 women) as a reference group. Plasma TMA and TMAO were measured by HPLC-MS/MS. The carotid study was ultrasonically assessed bilaterally by the quantification of intima-media thickness of both common carotid arteries (IMT-CC).
Results:
We found higher TMAO levels and TMAO/TMA ratio in CHD men than CHD women (p=0.034 and p=0.026, respectively). No TMA sex differences were found in CHD patients. The TMA and TMAO levels and TMAO/TMA ratio were lower, and no differences between sexes were found in the non-CVD population. TMAO levels in CHD patients were consistent with higher IMT-CC and more carotid plaques (p=0.032 and p=0.037, respectively) and lower cholesterol efflux in CHD men than CHD women (p<0.001).
Conclusions
Our results suggest that CHD men have augmented TMAO levels compared with CHD women, presumably as a consequence of higher rate of TMA to TMAO oxidation, which could be associated with CVD, as these sex differences are not observed in a non-CVD population.